By focusing on increased funding, tax incentives, and support for domestic manufacturing, the government aims to make healthcare more accessible and affordable for all.
A new study published in JAMA Network Open has found that while procedural prescription denials curb immediate drug costs, some denials result in increased acute care utilization and costs, which ...
With a sweep of the pen, President Donald Trump has ended a Biden administration effort to lower the cost of prescription drugs for people on Medicare and Medicaid.